Gilead HIV/AIDS 'blood booster' gets EU nod

Drug Discovery |  Regulatory | By BioSpectrum Bureau  | 1 Comment | 26 Sep, 2013

Singapore: Gilead Sciences has recieved European Commission marketing authorization approval for once-daily Tybost (cobi...Read more

Merck, AstraZeneca sign deal for cancer drug therapy

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 17 Sep, 2013

Singapore: Merck and AstraZeneca entered into a licensing agreement for Merck's oral small molecule inhibitor of WEE1 ki...Read more

Inversion of ibuprofen in body helps fight cancer: Study

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 30 Sep, 2013

Singapore: Scientists at the Department of Pharmacy and Pharmacology, University of Bath, UK, demonstrated that anti-inf...Read more

Australia ideal for early-stage drug development

Drug Discovery |  Opinion | By BioSpectrum Bureau  | 2 Comment | 14 Jun, 2012

Australia has a long history in biomedical research, with a reputation for excellence and invention since the early 1900...Read more

HUYA, Sanzao Park partner for drug development

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 11 Jun, 2012

Singapore: HUYA Bioscience, a leader in globalizing China's biopharmaceutical innovations, has signed a strategic partne...Read more

GSK's cancer drug gets EU marketing authorization

Drug Discovery |  Regulatory | By BioSpectrum Bureau  | 1 Comment | 16 Aug, 2013

Singapore: European Commission has granted an additional indication for GlaxoSmithKline's Tyverb (lapatinib) to be used ...Read more

Astellas completes patient recruitment in drug trial

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 19 Dec, 2012

Singapore: Japanese company Astellas Pharma has completed patient recruitment for the isavuconazole phase III registrati...Read more

Daiichi Sankyo expands drug discovery program

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 30 Jul, 2013

Singapore: Japan-based Daiichi Sankyo has decided to expand its collaborative drug discovery program with universities a...Read more

Boehringer terminates insulin deal with Lilly

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 08 Jan, 2013

Singapore: Eli Lilly and Boehringer Ingelheim are making a slight adjustment to their diabetes alliance with respect to...Read more

Cellmid gets positive sign with Midkine antibody for kidney disease

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2014

Singapore: Australia's Cellmid has completed its first in-life diabetic nephropathy study with anti-midkine antibodies (...Read more

Takeda Gemini II trial shows positive results

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 14 May, 2012

Singapore: Positive results were reported from Takeda Pharmaceutical's international, randomized, placebo-controlled, ...Read more

IOF, Fonterra grants $43K to Indonesian for bone R&D

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 25 Jul, 2013

Singapore: Global organization, International Osteoporosis Foundation (IOF), and New Zealand dairy firm, Fonterra have c...Read more

Vanda Pharma withdraws application for Fanaptum

Drug Discovery |  Regulatory | By BioSpectrum Bureau  | 1 Comment | 15 Mar, 2013

Singapore: Vanda Pharmaceuticals has withdrawn its application from European Medicines Agency for a centralized marketin...Read more

AbbVie invests $320 mn in bilogics manufacturing in Singapore

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2014

Singapore: Research based pharmaceutical company, AbbVie, has made investment of around USD320 million in Singapore to s...Read more

Prana Alzheimer's trial shows +ve results

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 08 Apr, 2013

Singapore: Prana Biotechnology reported on the progress of its lead development asset PBT2, which is in phase II trials ...Read more

Astellas to do interim analysis of cancer trial

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 03 Apr, 2013

Singapore: Medivation and Astellas Pharma have established an updated interim analysis plan for the Prevail trial, a glo...Read more

Novartis acquires cancer firm CoStim

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 18 Feb, 2014

Singapore: Global pharmaceutical firm, Novartis, has acquired CoStim Pharmaceuticals, a privately held biotechnology com...Read more

Cytos reveals trial data allergic asthma immune modulator

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 09 Sep, 2013

Singapore: Cytos Biotechnology revealed additional results of the phase IIa clinical trial with CYT003, a first-in-class...Read more